Effect of fucoidan on the regulation of antioxidant enzymes in hepatorenal tissues of streptozotocin-induced diabetic rats
By: Somanath, Deepa
.
Contributor(s): Vijayakumar. J.
Publisher: Mumbai Indian Journal of Pharmaceutical Science 2021Edition: Vol.83(6), Nov-Dec.Description: 1164-1173p.Subject(s): PHARMACEUTICSOnline resources: Click here
In:
Indian journal of pharmaceutical sciencesSummary: Accumulation of reactive oxygen species resulting from hyperglycemia and inadequate endogenous
antioxidants are responsible for the complications of diabetes. Accumulation of reactive oxygen species in
the cells stimulates apoptosis, which hampers the cell architecture and functions of vital organs. This study
investigates the effect of fucoidan from Sargassum wightii, a potent antioxidant with a regulatory effect
on blood glucose homeostasis, in the liver and kidney of diabetic rats. Diabetes was induced in rats by
administrating streptozotocin 50 mg/kg for 3 consecutive days through intraperitoneal injection. 30 male
Wistar rats were divided into five groups consisting of six animals in each group and they were Group A:
Control group, Group B: Diabetic group, Group C: Diabetic rats treated with metformin hydrochloride
250 mg/kg, Group D: Diabetic rats treated with fucoidan 50 mg/kg, and Group E: Diabetic rats treated
with fucoidan 100 mg/kg. Fucoidan was administrated orally for 4 w after the induction of diabetes.
Superoxide dismutase activity was low in the liver of the diabetic group and it showed 58.5 % activity,
compared with the control group. Fucoidan administration elevated superoxide dismutase and it was
66.5 % and 80.6 % respectively in fucoidan 50 mg/kg and fucoidan 100 mg/kg groups, compared with
the control group while in the metformin group 93.4 % activity was seen. A similar variation in the
superoxide dismutase was observed in the kidney; wherein, administration of fucoidan restored the
superoxide dismutase activity and it was 62.9 % in the fucoidan 50 mg/kg group and 79.5 % in the fucoidan
100 mg/kg group, compared with the control group while in diabetic group 49.4 % and metformin
group 94.2 % activity were observed. The other tested antioxidant enzymes such as catalase, glutathione
peroxidase and glutathione S transferase also showed marked regain in a dose-dependent manner upon
administration of fucoidan. This study inferred that the administration of fucoidan in streptozotocin-
induced diabetic rats improved the antioxidant enzyme activity by moderating the accumulation of
reactive oxygen species and reduced the pathophysiology.
| Item type | Current location | Call number | Status | Date due | Barcode | Item holds |
|---|---|---|---|---|---|---|
Articles Abstract Database
|
School of Pharmacy Archieval Section | Not for loan | 2022-1229 |
Accumulation of reactive oxygen species resulting from hyperglycemia and inadequate endogenous
antioxidants are responsible for the complications of diabetes. Accumulation of reactive oxygen species in
the cells stimulates apoptosis, which hampers the cell architecture and functions of vital organs. This study
investigates the effect of fucoidan from Sargassum wightii, a potent antioxidant with a regulatory effect
on blood glucose homeostasis, in the liver and kidney of diabetic rats. Diabetes was induced in rats by
administrating streptozotocin 50 mg/kg for 3 consecutive days through intraperitoneal injection. 30 male
Wistar rats were divided into five groups consisting of six animals in each group and they were Group A:
Control group, Group B: Diabetic group, Group C: Diabetic rats treated with metformin hydrochloride
250 mg/kg, Group D: Diabetic rats treated with fucoidan 50 mg/kg, and Group E: Diabetic rats treated
with fucoidan 100 mg/kg. Fucoidan was administrated orally for 4 w after the induction of diabetes.
Superoxide dismutase activity was low in the liver of the diabetic group and it showed 58.5 % activity,
compared with the control group. Fucoidan administration elevated superoxide dismutase and it was
66.5 % and 80.6 % respectively in fucoidan 50 mg/kg and fucoidan 100 mg/kg groups, compared with
the control group while in the metformin group 93.4 % activity was seen. A similar variation in the
superoxide dismutase was observed in the kidney; wherein, administration of fucoidan restored the
superoxide dismutase activity and it was 62.9 % in the fucoidan 50 mg/kg group and 79.5 % in the fucoidan
100 mg/kg group, compared with the control group while in diabetic group 49.4 % and metformin
group 94.2 % activity were observed. The other tested antioxidant enzymes such as catalase, glutathione
peroxidase and glutathione S transferase also showed marked regain in a dose-dependent manner upon
administration of fucoidan. This study inferred that the administration of fucoidan in streptozotocin-
induced diabetic rats improved the antioxidant enzyme activity by moderating the accumulation of
reactive oxygen species and reduced the pathophysiology.
Click on an image to view it in the image viewer
There are no comments for this item.